Skip header and navigation

9 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR Table EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR Table EOC
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR Table EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
March 4, 2022 What is the safety/efficacy of the Novavax vaccine? EOC220302 ESR EOC

9 records – page 1 of 1.